Sort
51,593 grants matching “hepatitis”
Drug Use, Disorder & HIV/AIDS Risk in Juvenile Justice Youth:A Longitudinal Study
$1,136,478Linda A Teplin · Northwestern University At Chicago · R01 · FY2007 · DA
Structure-Based Vaccine Design for Hepatits C Virus
$1,136,335Thomas R Fuerst · Univ Of Maryland, College Park · R01 · FY2019 · AI
TREATMENT OF LIVER INJURY AND FIBROSIS: SAFETY PHARMACOLOGY AND TOXICOLOGY
$1,136,111Michael Norman Krupp · Xfibra, Inc. · R44 · FY2020 · DK
Core J: Virology and Molecular Biomarkers
$1,136,053Guido Silvestri · Emory University · P30 · FY2022 · AI
Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy
$1,135,896Yaron Rotman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
Combinational Immunotherapies to Amplify Vaccine Induced Immunity
$1,135,847Elizabeth Marion Jaffee · Johns Hopkins University · U19 · FY2007 · CA
Pittsburgh Liver Research Center
$1,135,501Satdarshan Singh Monga · University Of Pittsburgh At Pittsburgh · P30 · FY2020 · DK
Mechanisms of repeated control of acute hepatitis C infection in humans
$1,135,370Andrea L Cox · Johns Hopkins University · U19 · FY2019 · AI
Modeling human hepatotropic infections in complex tissue organoids
$1,135,336Charles M. Rice · Rockefeller University · R01 · FY2009 · DK
Miami Treatment and Prevention Clinical Trials Unit (CTU)
$1,135,209Margaret A Fischl · University Of Miami School Of Medicine · UM1 · FY2015 · AI
HCV replication and immunity
$1,134,402Research Inst Nationwide Children'S Hosp · U19 · FY2001 · AI
USC RESEARCH CENTER FOR LIVER DISEASES
$1,133,433University Of Southern California · P30 · FY2005 · DK
DIABETES PREVENTION PROGRAM (DPP)
$1,133,215Yeshiva University · U01 · FY2001 · DK
JOHNS HOPKINS ADULT AIDS CLINICAL TRIALS UNIT
$1,132,476Johns Hopkins University · U01 · FY2005 · AI
Genes, Androgens and Intrauterine Environment in PCOS
$1,132,354Andrea Dunaif · Northwestern University At Chicago · P50 · FY2007 · HD
Drug Use, Disorder & HIV/AIDS Risk in Juvenile Justice Youth:A Longitudinal Study
$1,132,219Linda A Teplin · Northwestern University At Chicago · R01 · FY2008 · DA
Phosphoinositide-calcium Signaling In Cell Regulation
$1,131,825Tamas Balla · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2010 · HD
Symptomatic Toxicities & Quality of Life among Diverse Individuals Receiving Immune Checkpoint Inhibitors for Metastatic Cancer.
$1,131,820Patricia Ingrid Moreno · University Of Miami School Of Medicine · R37 · FY2025 · CA
MPS Qualification Section
$1,131,489Mark E Schurdak · University Of Pittsburgh At Pittsburgh · U2C · FY2025 · TR
Preservation & Replacement of Beta Cells in IDDM
$1,131,467Norman S. Fleischer · Albert Einstein College Of Medicine · P01 · FY2006 · DK
RISK OF HEPATOCELLULAR CANCER AFTER VIROLOGICAL CURE WITH DIRECT ACTING ANTIVIRAL AGENTS IN INDIVIDUALS WITH HEPATITIS C
$1,130,630Baylor College Of Medicine · · FY2019 · Defense Health Agency
The Ohio State University AIDS Clinical Trials Unit
$1,129,143Susan L Koletar · Ohio State University · UM1 · FY2013 · AI
Structure-Based Vaccine Design for Hepatits C Virus
$1,128,779Thomas R Fuerst · Univ Of Maryland, College Park · R01 · FY2020 · AI
NorthStar Node of the Clinical Trials Network
$1,128,775Gavin Bart · Hennepin Healthcare Research Institute · UG1 · FY2022 · DA
VACCINATION AGAINST INTRAPARTUM HIV CLADE C TRANSMISSION
$1,128,280Dana-Farber Cancer Institute · P01 · FY2000 · AI